Simian Vaccine Evaluation Units

The Simian Vaccine Evaluation Units (SVEU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, awarded by the National Institute of Allergy and Infectious Diseases (NIAID), supports preclinical research focused on HIV/AIDS vaccine development and prevention strategies using nonhuman primates. The contract enables NIAID to conduct comprehensive scientific studies involving nonhuman primate resources, including vaccine immunogenicity testing, efficacy assessments, and virus stock evaluations. The SVEU vehicle supports a wide range of research activities, from maintaining nonhuman primate colonies to conducting specialized vaccine and prevention strategy studies across multiple biosafety levels.

The SVEU IDIQ encompasses four primary task areas: administrative support, nonhuman primate maintenance, conducting studies in nonhuman primates, and operating a nonhuman primate breeding colony. Task orders typically range from $650,000 to $9,000,000, with performance periods extending up to seven years. Prime contractors include Tulane University, Bioqual, Inc., and the University of Louisiana at Lafayette, who have been awarded task orders for maintaining primate colonies, conducting specific vaccine studies, and providing administrative support. The contracts are predominantly cost-no-fee or cost-plus-fixed-fee, with no specific set-aside designations. Performance locations include research facilities in Louisiana, Maryland, and New Orleans, focusing on biosafety level 2 and 3 (ABSL2/ABSL3) environments dedicated to advancing HIV/AIDS research methodologies.